US Stock MarketDetailed Quotes

EDIT Editas Medicine

Watchlist
  • 1.440
  • -0.450-23.81%
Close Dec 13 16:00 ET
  • 1.450
  • +0.010+0.69%
Post 20:01 ET
118.87MMarket Cap-0.57P/E (TTM)

Editas Medicine Key Stats

Editas Medicine Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.333M--
--2024/Q4-- / 37.333M--
--2024/Q361.000K / 3.894M--
Aug 7, 20242024/Q2513.000K / 4.142M--
May 8, 20242024/Q11.135M / 7.296M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.333M--
--2024/Q4-- / 37.333M--
--2024/Q361.000K / 3.894M--
Aug 7, 20242024/Q2513.000K / 4.142M--
May 8, 20242024/Q11.135M / 7.296M--

Unlock Free Earnings Estimates

Editas Medicine Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 13, 2024

Hold

  • Buy

    25.00%
  • Hold

    68.75%
  • Sell

    6.25%

Price Target

No Data